Skip to content
value.today

Jubilant Life Sciences

JUBILANT.BO
$1.6 Bmarket cap on Nov 20, 2026
1D
+0.9%
Compare
World rank
#7,259
Revenue
—
annual
Net income
—
Employees
2,554
As on March 2020
value.today research

Jubilant Life Sciences in brief

Jubilant Life Sciences is a listed company in the Pharmaceutical industry, based in India. It was founded in 1978. Its market value was $1.6 B on 20 November 2026, which makes it the 7,259th largest listed company in the world and the 469th largest in India on this site. It employs about 2,554 people. Its shares trade under the symbol JUBILANT.BO (BSE).

Written from the figures on this page, so it changes when they do. The date of each figure is under How current the figures are.

Jubilant Life Sciences timeline

2 events, 1978–2003
  1. 1978
  2. 🏁
    Founded
  3. 2003
  4. 📈
    Listed on National Stock Exchange of India as JUBLPHARMA
    First day of listing in the exchange's official list.

Events of Jubilant Life Sciences from Wikidata and the exchanges' official lists. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Jubilant Life Sciences share price · NSE (JUBLPHARMA.NS)

daily · 1,424 trading days since 2021
Last close 935.05 INR (Nov 20, 2026)1 month: +0.6%1 year: -13.4%5 years: +53.1%52-week range 786.05 – 1,119 INR
$0 M$341 M$682 M$1.0 B$1.4 B20222023202420252026

Also priced on: NSE (JUBILANT.NS)

DateOpenHighLowCloseChangeVolume
Nov 20, 2026936.60944.95921.20935.05+0.2%163,615
Nov 19, 2026933.00937.75914.00933.25-0.0%191,837
Nov 18, 2026949.95953.90931.00933.60-2.2%135,312
Nov 17, 2026970.00987.00942.70954.50-0.6%193,212
Nov 16, 2026950.001,001927.95960.25-0.4%282,886
Nov 13, 2026976.50982.20960.80964.10-1.9%54,761
Nov 12, 2026993.00999.50971.60982.95-0.5%60,858
Nov 11, 2026976.30993.80967.00987.50+2.2%103,221
Nov 9, 2026942.95975.00933.85966.00+2.8%112,791
Nov 6, 2026946.00954.40934.10939.60-0.8%58,214
Nov 5, 2026945.30953.95927.95947.05+0.8%77,380
Nov 4, 2026940.00953.00933.00939.55+0.1%50,216
Nov 3, 2026949.00956.00936.05938.75-0.8%46,594
Nov 2, 2026925.00949.90919.00946.75+2.5%148,076
Oct 30, 2026946.00951.80920.00923.80-2.3%56,229
Oct 29, 2026943.90956.10937.30946.00+0.2%45,198
Oct 28, 2026953.30959.80936.40943.90-1.7%57,068
Oct 27, 2026939.80965.90931.40959.80+2.4%143,473
Oct 26, 2026938.30941.30918.00937.00-0.1%81,042
Oct 23, 2026932.00944.80895.10938.30+0.7%142,183
Oct 22, 2026928.00944.80913.00932.20+0.3%107,635
Oct 21, 2026938.20938.50911.60929.40-0.7%177,629
Oct 19, 2026931.60948.40931.50935.80-0.3%80,672
Oct 16, 2026938.20954.90928.60938.60+0.0%134,966
Oct 15, 2026939.90949.00919.70938.20-0.1%208,268
Oct 14, 2026945.00948.90928.50938.90-0.4%391,864
Oct 13, 2026956.20956.30921.40942.50-0.9%457,491
Oct 12, 2026931.90969.90908.00950.90+2.0%1.4 M
Oct 9, 2026940.40950.00917.60931.90-0.0%123,186
Oct 8, 2026971.00974.60921.50932.20—417,017

Prices in INR from the National Stock Exchange of India; the last 30 trading days are listed, the chart shows up to ten years. For information only; not investment advice.

Jubilant Life Sciences share price statistics

computed nightly from the daily prices
NSE · JUBLPHARMA.NSClose 935.05 INR (Nov 20, 2026)
1 day
+0.2%
1 week
-3.0%
1 month
-0.1%
3 months
+7.3%
Year to date
-12.9%
1 year
-13.4%
3 years
+114.8%
5 years
+53.1%
10 years
—
52-week low 786.05-16.4% from the highhigh 1,119
Highest on record 1,310 INR (Nov 7, 2024)Volume 190,762 shares/dayValue traded 180.3 M INR/dayVolatility 24% (30d), 29% (1y)1,424 trading days on record
NSE · JUBILANT.NSClose 903.60 INR (Feb 11, 2021)
1 day
-3.1%
1 week
+0.1%
1 month
-1.3%
3 months
+31.2%
Year to date
+7.0%
1 year
+67.5%
3 years
-4.1%
5 years
—
10 years
—
52-week low 234.35-13.7% from the highhigh 1,047
Highest on record 1,047 INR (Feb 3, 2021)Volume 510,256 shares/dayValue traded 480.9 M INR/dayVolatility 66% (30d), 60% (1y)1,051 trading days on record

Changes compare closing prices; volatility is the annualised standard deviation of daily returns. Prices are as published by the exchange, not adjusted for splits, bonus issues or dividends. For information only; not investment advice.

Market cap history

$0 M$501 M$1.0 B$1.5 B$2.0 B2020202120222023202420252026

World rank over time

▼ down 353 places since 2020
2020-01-01: #6902#6,90220202021-01-01: #5716#5,71620212022-12-25: #10096#10,09620222026-11-12: #7123#7,12320262026-11-13: #7236#7,23620262026-11-16: #7197#7,19720262026-11-17: #7212#7,21220262026-11-18: #7300#7,30020262026-11-19: #7287#7,28720262026-11-20: #7255#7,2552026

Rank in India: #253 (Jan 2020) · #216 (Jan 2021) · #450 (Dec 2022) · #456 (Nov 2026) · #464 (Nov 2026) · #458 (Nov 2026) · #461 (Nov 2026) · #471 (Nov 2026) · #471 (Nov 2026) · #467 (Nov 2026)

Mutual funds holding Jubilant Life Sciences#

45 funds in 2 countries hold shares worth $65 M. Since their previous reports 8 added shares and 10 sold, selling $32 M net. By country: USA 41 ($57 M), India 4 ($9 M).
Mutual funds holding Jubilant Life Sciences
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 iShares Core MSCI Emerging Markets ETFBlackRock Fund Advisors935,532$10 M—<0.01%+0.0%May 31, 2026
🇺🇸 Vanguard Total International Stock Index FundThe Vanguard Group, Inc.997,284$10 M—<0.01%no changeJul 31, 2026
🇺🇸 Vanguard Emerging Markets Stock Index FundThe Vanguard Group, Inc.939,993$9 M—<0.01%no changeJul 31, 2026
🇺🇸 Emerging Markets Core Equity 2 PortfolioDimensional Fund Advisors LP678,091$7 M—0.02%no changeJul 31, 2026
🇮🇳 Aditya Birla Sun Life Small Cap FundAditya Birla Sun Life AMC500,687$5 M—0.79%no changeOct 31, 2026
🇺🇸 Dimensional Emerging Markets Value FundDimensional Fund Advisors LP405,731$4 M—0.03%no changeJul 31, 2026
🇺🇸 Vanguard Ftse All-World Ex-Us Small-Cap Index FundThe Vanguard Group, Inc.265,623$3 M—0.02%no changeJul 31, 2026
🇺🇸 The Emerging Markets Small Cap SeriesDimensional Fund Advisors LP234,336$2 M—0.07%no changeJul 31, 2026
🇮🇳 Motilal Oswal Nifty Microcap 250 Index FundMotilal Oswal Asset Management214,139$2 M—0.92%−1.9%Oct 31, 2026
🇺🇸 iShares Core MSCI Total International Stock ETFBlackRock Fund Advisors164,384$2 M—<0.01%no changeJul 31, 2026
🇺🇸 State Street SPDR Portfolio Emerging Markets ETFSSGA Funds Management, Inc.135,019$1 M—<0.01%no changeJun 30, 2026
🇺🇸 iShares MSCI India Small-Cap ETFBlackRock Fund Advisors128,534$1 M—0.21%−6.5%May 31, 2026
🇺🇸 Avantis Emerging Markets Equity ETFAmerican Century ETF Trust107,093$1 M—<0.01%+3.9%May 31, 2026
🇮🇳 Aditya Birla Sun Life Bal Bhavishya YojnaAditya Birla Sun Life AMC105,213$1 M—0.83%no changeOct 31, 2026
🇺🇸 Dimensional Emerging Markets Core Equity 2 ETFDimensional Fund Advisors LP96,248$1 M—0.01%no changeJul 31, 2026
🇺🇸 Vanguard Total World Stock Index FundThe Vanguard Group, Inc.64,837$1 M—<0.01%no changeJul 31, 2026
🇮🇳 Aditya Birla Sun Life Pharma & Healthcare FundAditya Birla Sun Life AMC63,087$1 M—0.54%no changeOct 31, 2026
🇺🇸 Dimensional Emerging Core Equity Market ETFDimensional Fund Advisors LP54,860$1 M—<0.01%+9.0%Jul 31, 2026
🇺🇸 Fidelity Total International Index FundFidelity Management & Research Company LLC54,588$1 M—<0.01%−5.6%Jul 31, 2026
🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC49,061$1 M—<0.01%no changeJun 30, 2026
🇺🇸 State Street SPDR S&P Emerging Markets Small Cap ETFSSGA Funds Management, Inc.42,459$0 M—0.06%−2.9%Jun 30, 2026
🇺🇸 Dimensional Emerging Markets Value ETFDimensional Fund Advisors LP39,990$0 M—0.02%+2.6%Jul 31, 2026
🇺🇸 Dimensional World ex. U.S. Core Equity 2 ETFDimensional Fund Advisors LP38,624$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Emerging Markets Social Core Equity PortfolioDimensional Fund Advisors LP29,820$0 M—0.01%no changeJul 31, 2026
🇺🇸 WisdomTree India Earnings FundWisdomTree Asset Management, Inc.24,309$0 M—0.01%−5.6%Jun 30, 2026

As of Oct 31, 2026

Where Jubilant Life Sciences operates: 1 country#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.

Present: offices, subsidiaries, branches or revenue (1 country)Nothing on fileDots mark countries too small to see. Hover, tap or tab to a country for its figures.

Only the headquarters country is on file for Jubilant Life Sciences: no subsidiaries, branches, offices or country revenue elsewhere in the GLEIF register, its SEC filings or Wikidata.

Jubilant Life Sciences: countries of operation
CountryPresenceRevenue there
🇮🇳 IndiaHeadquarters1 office—

FDA drug approvals: Jubilant Life Sciences#

56 approved applications held; 2 approvals and 0 new uses in 2026.

Approvals held
56
New molecular entities
0
New uses approved
2
efficacy supplements
Generics
51
5 new drugs, 0 biologics
Jubilant Life Sciences: latest FDA approvals
ApprovedDrugKind
2026-08-17TadalafilTadalafil · ANDA210592Generic drug (ANDA)
2026-05-15TadalafilTadalafil · ANDA210329Generic drug (ANDA)
2025-08-05BumetanideBumetanide · ANDA212470Generic drug (ANDA)
2025-08-04Eslicarbazepine AcetateEslicarbazepine Acetate · ANDA211219Generic drug (ANDA)
2025-05-20PregabalinPregabalin · ANDA209530Generic drug (ANDA)
2025-04-15RanolazineRanolazine · ANDA211361Generic drug (ANDA)
2025-04-11DeferasiroxDeferasirox · ANDA211660Generic drug (ANDA)
2025-03-18PerphenazinePerphenazine · ANDA213694Generic drug (ANDA)
2025-03-06Sildenafil CitrateSildenafil Citrate · ANDA202954Generic drug (ANDA)
2025-03-03Oseltamivir PhosphateOseltamivir Phosphate · ANDA213695Generic drug (ANDA)
2024-12-20Sildenafil CitrateSildenafil Citrate · ANDA201156Generic drug (ANDA)
2024-12-06Lurasidone HydrochlorideLurasidone Hydrochloride · ANDA210388Generic drug (ANDA)
2024-10-02Solifenacin SuccinateSolifenacin Succinate · ANDA205484Generic drug (ANDA)
2023-11-09Technetium Tc-99M Sulfur Colloid KitTechnetium Tc-99M Sulfur Colloid Kit · ANDA213516Generic drug (ANDA)
2018-05-14NiacinNiacin · ANDA209156Generic drug (ANDA)
2018-02-07Amantadine HydrochlorideAmantadine Hydrochloride · ANDA210403Generic drug (ANDA)
2018-01-29Clonidine HydrochlorideClonidine Hydrochloride · ANDA210338Generic drug (ANDA)
2017-12-26Draximage Dtpanew useTechnetium Tc-99M Pentetate Kit · NDA018511 (SUPPL-28)New drug (NDA)
2017-08-25IndomethacinIndomethacin · ANDA205215Generic drug (ANDA)
2017-08-17Drax ExametazimeTechnetium Tc-99M Exametazime Kit · NDA208870New drug (NDA)
2017-08-04Tizanidine HydrochlorideTizanidine Hydrochloride · ANDA209605Generic drug (ANDA)
2017-06-30Bupropion HydrochlorideBupropion Hydrochloride · ANDA207459Generic drug (ANDA)
2017-05-15Amlodipine And Olmesartan MedoxomilAmlodipine Besylate, Olmesartan Medoxomil · ANDA207450Generic drug (ANDA)
2017-04-24Olmesartan MedoxomilOlmesartan Medoxomil · ANDA205482Generic drug (ANDA)
2017-04-04CelecoxibCelecoxib · ANDA207061Generic drug (ANDA)

Discuss Jubilant Life Sciences#

1 automatic updates and 0 member comments. Sign in to comment and react.

  • Mutual funds: 45 funds hold $65 millionautomatic update · Oct 31, 2026

    45 mutual funds in 2 countries hold shares of Jubilant Life Sciences worth $65 million (funds' newest reports, up to 31 October 2026). Since their previous reports 8 funds added shares and 10 sold; on balance they sold $32 million. Share splits are not counted as trading.

How Jubilant Life Sciences compares in Pharmaceutical

Peer comparison · Pharmaceutical

CompanyMarket capP/ENet marginRev. growth
Jubilant Life Sciences🇮🇳$1.6 B———
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Amgen Inc.🇺🇸$249.2 B26.5×24.1%+9.9%
AstraZeneca PLC🇬🇧$242.6 B23.7×17.4%+8.6%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

How current the figures are

Market cap:
Nov 20, 2026
Employees:
As on March 2020
Profile updated:
Nov 22, 2026

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Jubilant Life Sciences? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Jubilant Life Sciences's ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Jubilant Life Sciences? Suggest a correction